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A B S T R A C T  
Dried aerial parts of Chenopodium album Linn. (Chenopodiaceae) are used in 
variety of diseases in traditional Indian system of medicine including hepatic 
ailments. The aim of present study was to validate hepatoprotective activity of 
aerial parts of Chenopodium album Linn using alcohol as chronic hepatitis 
model. Alcoholic [ALCA] and aqueous [ AQCA] extracts of the aerial parts of 
Chenopodium album  at the doses of 200 and 400 mg/Kg  were evaluated 
for hepatoprotective activity against alcohol induced hepatotoxicity using 
biochemical markers and by histopathological method. The aqueous extract at 
a dose of 400 mg/kg was found to be more potent when compared to Silymarin. 
ALCA and AQCA [200 & 400 mg/Kg] showed significant 
hepatoprotective activity against alcohol induced hepatotoxicity as evident by 
restoration of serum transaminases, alkaline phosphatase and bilirubin content. 
Histopathology of the liver tissue further confirmed the reversal of damage 
induced by hepatotoxin.Present study showed that the alcoholic and aqueous 
extracts of Chenopodium album significantly restore physiological integrity of 
hepatocytes. Aqueous and alcoholic extract did not show any sign of toxicity up 
to oral dose of 5 g/Kg in mice. 
Keywords: Chenopodium album Linn; hepatoprotective activity; alcohol; chronic 
hepatitis model; serum biochemical assessment; histopathology. 
 
Introduction 
Liver diseases have become a global concern 
worldwide. The principal causative factor is increasing 
alcohol consumption, infection, malnutrition, anemia 
and availability of hepatotoxic drugs over the counter. 
Treatment options for common liver diseases such as 
cirrhoses, fatty liver and chronic hepatitis are 
problematic. The conventional drugs used in the 
treatment of liver diseases viz., corticosteroids, 
antiviral and immunosuppressant agents are 
sometimes inadequate and may lead to serious 
adverse effects. Paradoxically, these may themselves 
cause hepatic damage. Eg: cholestatic jaundice with 
azathioprine and elevation of serum transaminases by 
interferon and virazole [1]. It is therefore imperative to 
search alternative drugs for the treatment of liver 
disease to replace the currently used drugs of doubtful 
efficacy and safety [2]. In absence of a reliable liver 
protective drug in the modern system of medicine, a 
number of medicinal preparations in Ayurveda, the 
Indian system of medicine, are recommended for the 
treatment of liver disorders. Natural remedies from 
medicinal plants are considered to be effective and 
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In such context, one such drug is Chenopodium album 
Linn which has ethno pharmacological relevance to be 
used for hepatic disorders [3]. Chenopodium album  
Linn (Chenopodiaceae) found wild  up to an altitude of 
4700 m and cultivated throughout India particularly 
Western Rajasthan, Kulu valley and Shimla. It is 
commonly known as Lamb’s quarte, wild spinach, 
white goosefoot in English [4, 5]. In Tradition System of 
Medicine, it is used as an anthelmintic,antidiarrhoeal, 
antiphlogistic, antirheumatic, contraceptive, odontalgic, 
laxative, cardiotonic, antiscorbutic, blood purifier, 
hepatic disorder, spleen enlargement, biliousness, 
intestinal ulcers, digestive, carminative, aphrodisiac, 
dyspepsia, flatulence, strangury, seminal weakness, 
pharyngopathy, splenopathy, hemorrhoids, 
ophthalamopathy, cardiac disorder and general debility 
[6-9].The phytoconstituents isolated so far from the 
plant are ascorbic acid,  β-carotene, catechin, 
gallocatechin, caffeic acid, p-coumaric acid, ferulic 
acid,  β-sitosterol, campesterol, xanthotoxin, 
stigmasterol, n-triacontanol, imperatorin, ecdysteroid 
[10], cinnamic acid amide alkaloid[11], phenol, 
saponin, apocartenoids[12], crytomeridiol[13], n-trans-
feruloyl-4-O-methyl dopamine and syringaresinol [14] 
and β-sitosterol, lupeol and 3 hydroxy nonadecyl 
henicosanoate [15]. The pharmacological activity 
reported so far from this plant are antipruritic, 
antinociceptive activity [16], anthelmintic activity [17], 
as vaginal contraceptive [18], antibactertial activity 
[19], antiulcer activity [20] and hepatoprotective against 
paracetamol induced hepatotoxicity [21].  
 
As there is not report on hepatoprotective activity, this 
prompted us to investigate the hepatoprotective activity 
of aerial parts of Chenopodium album extracts. 
 
Materials and Methods 
Plant Material  
Plant material used in the study consisted of aerial 
parts of Chenopodium album Linn, collected from the 
local area of Nadaun, Distt. Hamirpur (H.P.), and 
authenticated by Dr. Sushil Vashi, Reader, Department 
of Botany, Govt Degree College of Arts, Commerce 
and Science, Hamirpur (H.P.). A voucher specimen is 
preserved in the Department.  
 
Preparation of plant extract: 
Crude aerial parts of Chenopodium album were 
subjected to pulverizations and passed through sieve 
no. 40. The powder [300 g] was packed into a soxhlet 
apparatus and extracted with petroleum ether (60-80º 
C) for 18 h. The same marc was successively 
extracted with alcohol and afterwards with distilled 
water for 18 hours. Each time the marc was dried and 
later extracted with other solvents. All the extract were 
concentrated by rotary vacuum evaporator and 
evaporated to dryness and the percentage yield was 
found to be 2.3, 0.6 and 15.3 % w/w respectively.  
 
Chemicals 
Silymarin (Sigma Chemicals, USA) and alcohol (CDH, 
Mumbai) were purchased. Other chemicals and 
reagents used for extraction were of AR grade. 
Biochemical kits like AST, ALT, ALP, albumin, total 
protein, direct bilirubin and total bilirubin were obtained 
from Span Diagnostics Ltd. Surat, India. 
Experimental Animal 
Wistar albino rats (150-200g) were maintained in the 
animal house of Despanday labs, M.P. 
Nagar, Bhopal (M.P.) for experimental purpose. Then 
all the animals were acclimatized for  
seven days under standard husbandry conditions, i.e. 
room temperature of 25 ± 10 C; relative 
humidity 45-55% and a 12:12h light/ dark cycle. The 
animals had free access to standard rat 
pellet, with water supplied ad libitum under strict 
hygienic conditions. Animals were habituated to 
laboratory conditions for 48 hours prior to experimental 
protocol. All the protocols and the experiments were 
conducted in strict compliance according to ethical 
principles and guidelines provided by Committee for 
the Purpose of Control and Supervision of Experiments 
on Animals (CPCSEA). 
 
Experimental Study 
Determinations of Acute Oral Toxicity (LD50) 
The acute oral toxicity (AOT) of alcoholic and aqueous 
extract of aerial parts of Chenopodium album were 
determined by using female albino rats (Wistar strains) 




weighing between 180-220 g.The animals were fasted 
3 hrs prior to the experiment, up and down procedure 
(OECD Guideline no. 425). Animals were administered 
with single dose of extracts dissolved in 2% w/v acacia 
and observed for its mortality during 48 hours study 
period (short term) toxicity. Based on short-term profile 
of drug, the dose of the next animals was determined 
as per as OECD guideline 425. All the animals were 
also observed for long term toxicity (14 Days). The 
LD50 of the test extract was calculated using AOT 425 
software provided by Environmental protection agency, 
USA. 
 
Evaluation of Hepatoprotective Activity 
The alcoholic and aqueous extracts were evaluated for 
their hepatoprotective activity using alcohol induced 
chronic hepatic injury [22]. Wistar rats, weighing (180-
220 g) were divided into 7 groups consisting of 6 
animals in each group.  
Group 1: Normal group: animal of this group receive 
distilled water p.o. for 30 days. 
                    
Group 2: Control group: animal of this group received 
vehicle and alcohol 3ml/ 100g/day p.o. for 30 days. 
    
Group 3:  Standard group: animal of this group receive 
Silymarin 50 mg/ Kg/day p.o. and alcohol 3 ml/ 100 
g/day p.o. for 30 days. 
                    
Group 4: Test group: animal of this group receive 
alcoholic extract of aerial parts of Chenopodium album 
200 mg/Kg/day and alcohol 3 ml/ 100 g/day p.o. for 30 
days. 
 
Group 5: Test group: animal of this group receive 
alcoholic extract of aerial parts of Chenopodium album 
400 mg/Kg/day and alcohol 3 ml/100 g/day p.o. for 30 
days. 
 
Group 6: Test group: animal of this group receive 
aqueous extract of aerial parts of Chenopodium album 
200 mg/Kg/day and alcohol 3 ml/100 g/day p.o. for 30 
days. 
 
Group 7: Test group: animal of this group receive 
aqueous extract of aerial parts of Chenopodium album 
400 mg/Kg/day and alcohol 3 ml/100 g/day p.o. for 30 
days                   
Alcohol (28.5%) was given 3 ml/100 g/day in two 
divided doses after one hour of drugs treatment of 
Group 2, 3, 4, 5, 6, and 7 for 30 days. 
 
Blood samples were collected and serum was used for 
estimation of Asparate aminotransferase [AST], 
Alanine aminotransferase [ALT], alkaline phosphatase 
[ALP], albumin [ALB], total protein [TLP], total bilirubin 
[TBIL] and direct bilirubin [DBIL]. The liver was washed 
by normal saline, blotted with filter paper and weighed 
immediately (Mastuda et al., 1991).  
 
Histopathological studies: 
Liver was sliced and pieces were preserved in 10% 
formalin for proper fixation. These tissues were 
processed and embedded in paraffin wax. Section of 
5- 6 microns in thickness were cut and stained with 
hematoxylin and eosin. All the sections of the tissues 
were examined under microscope for analyzing the 
altered architecture due to the liver tissue due to 
paracetamol challenge and improved liver architecture 
due to pretreatment with test extracts and standard 
drug [23] which was documented by photograph. 
 
Statistical analysis 
Results were expressed as mean ± SEM. Statistical 
analysis was carried out using one-way ANOVA 
followed by Tukey Kramer’s Post Hoc Test. 
 
Results 
Acute Oral Toxicity Study: 
Different doses of alcoholic and aqueous extracts were 
screened for their oral toxicity. No mortality was 
recorded till 5000 mg/Kg with alcoholic and aqueous 
extracts, hence the extracts were found to be safe up 
to the dose levels of 5000 mg/Kg.  
 
Alcohol induced acute hepatic injury: 
Liver weight and volume:  
Administration of alcohol has produced a significant 
increase in wet liver weight and volume. Rats 
pretreated with Silymarin (50 mg/Kg, p.o.), AQCA (400 




mg/Kg, p.o.) and ALCA (400 mg/Kg, p.o.) showed 
significant decrease in liver weight and volume 
compared to the toxic control group [Table 1 and Fig 
1]. 
Serum Biochemical parameter: 
Alcohol (3 ml/100 g/p.o.; b.i.d.) administration resulted 
in significant elevated the biochemical parameters like 
AST, ALT, ALP, direct bilirubin and total bilirubin 
levels, while albumin and total protein were found to be 
decreased compared to normal group. Pretreatment 
with Silymarin, AQCA and ALCA significantly 
prevented the biochemical changes induced by 
paracetamol. The hepatoprotective effect offered by 
AQCA (400 mg/Kg, p.o.) was found to be significantly 
greater than ALCA (400 mg/Kg, p.o.) and standard 




In normal animals, liver sections showed normal 
hepatic cells with well preserved cytoplasm, prominent 
nucleolus and central vein (Fig 5 A). 
 
In alcohol (3 ml/ 100g, p.o. for 30 days) treated animals 
the sections shows sever degree of liver damage, 
showing congestion, macrovesicular and 
microvesicular steatotsis (Fig 5B). 
 
 In AQCA (400 mg/Kg, p.o.) treated animals, liver 
section showing mild inflammation and congestion, 
overall picture resembles normal liver (Fig 5C). 
 
In ALCA (400 mg/Kg, p.o.) treated animals, the liver 
sections showing moderate inflammation and 
congestion (Fig 5D). 
 
In Silymarin (50 mg/Kg, p.o.) treated animals, the liver 
sections showing inflammation in the periportal region 
and moderate congestion (Fig 5E). 
 
Discussion 
The liver can be injured by many chemicals and drugs. 
In the present study, alcohol was selected as a 
hepatotoxicant to induced liver damage. The primary 
objective of this study is to assess the hepatoprotective 
activity of Chenopodium album against chronic liver 
damage.  
 
In the case of alcoholic liver disease (ALD), no such 
comprehensive animal model currently exists. 
Researchers have not been able to develop this model 
for reasons that are not understood as yet, but which 
probably involve genetic differences between humans 
and other animals [24]. 
 
In the absence of a comprehensive model, ALD 
studies using animals are designed to answer specific 
questions about different aspects of the disease, 
usually addressing only one or two experimental 
variables at a time while holding others constant. 
Consequently, it was through interesting to standardize 
a model using alcohol as hepatotoxic agent and to 
screen various indigenous drugs for their 
hepatoprotective action [22, 24].Ethanol, even after 
short-term consumption, induced CYP2E1 enzyme 
activity in doses that do not causes fatty changes. This 
enzyme accelerates alcohol metabolism with a 
resultant increase in acetaldehyde productions [25]. 
Acetaldehyde is thought to have number of adverse 
effects like decreased transport and secretion of 
proteins owing to tubulin polymerization, enhanced 
vitamin metabolisms and traces metals, which lead to 
fatal liver disorder [26, 27, 28].  
 
The hepatotoxic dose (3 ml/100 g/b.i.d. for 30 days) of 
alcohol produced an elevation in the liver weight & 
volume and serum AST, ALT, ALP, direct and total 
bilirubin, while albumin and total protein were found to 
be decreased compared to normal group.  In 
experimental animals pretreated with Chenopodium 
album linn. extracts (AQCA & ALCA) and silymarin, the 
total liver weight & volumes, AST, ALT, ALP, direct and 
total bilirubin levels were significantly lowered, while 
albumin and total protein significantly increased. 
Histopathological changes such as sever congestion, 
macro vesicular and microvesicular steatosis (fatty 
changes in hepatocytes) were observed in alcohol 
treated (toxic) groups. Both extracts prevented these 
histopathological changes, further indicating their 
hepatoprotective activity.   
 





Table 1: Effect of Silymarin, AQCA and ALCA on total liver weight and volume in Alcohol induced 


































Values are expressed as mean ± S.E.M;  n = 6. 
  ** P <0.01, *** P <0.001 vs. control (Toxic), using one-way ANOVA followed by Tukey Kramer’s Post Hoc test. 











Mean liver weight 
(g/100g) 
Mean liver volume 
(ml/100g) 






2 2 %w/v acacia + 
Alcohol 
3 ml/100 g, p.o. 
5.686 
± 0 .23 
6.09 
± 0.21 
3 Silymarin (50 mg/ Kg, 
p.o.) + Alcohol (3 





4 AQCA (200 mg/Kg, 
p.o.) + 






5 AQCA (400 mg/Kg, 
p.o.) + 






6 ALCA (200 
mg/Kg,p.o.) + 






7 ALCA (400 mg/ 
Kg,p.o.) + 










Table 2: Effect of Silymarin, AQCA and ALCA on different biochemical parameters in alcohol 
induced hepatotoxicity in rats. 
 
 
Values are expressed as mean ± S.E. M;  n = 6. 
  *** P <0.001 vs. control (Toxic), using one-way ANOVA followed by Tukey Kramer’s Post Hoc test. 
 
ALCA (Alcoholic extract of Chenopodium album ); AQCA (Aqueous extract of Chenopodium album ). AST 
(aspirate aminotransferase), ALT (alanine aminotransferase), ALP (alkaline phosphatase), ALB (albumin), TLP 








































2. 2 %w/v acacia + 
Alcohol 















3. Silymarin (50 mg/ 
Kg, p.o.) + Alcohol 






















4. AQCA (200 
mg/Kg, p.o.) + 





















5. AQCA (400 
mg/Kg, p.o.) + 























6. ALCA (200 
mg/Kg,p.o.) + 



















7. ALCA (400 mg/ 
Kg,p.o.) + 


















































Normal Control (toxic) Silymarin (50 
mg/kg) 




** P < 0.01, *** P < 0.001 compared with control[toxic] 
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 ** P < 0.001 compared with control [toxic] 
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CONCENTRATION  (g/dL) 
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Fig 5: Sections stained with hematoxylin and eosin (400 X) displaying the liver sections of rats 





















































Thus result of present study clearly demonstrate that 
the various biochemical (serum AST, ALT, ALP, 
albumin, total protein, direct bilirubin and total protein 
levels), physical (liver weight & volume) and 
histopathological alterations produced by Paracetamol 
in the serum and tissue were reserved significantly by 
the pretreatment with extracts of Chenopodium album 
and in standard group.  
 
From the results, the hepatoprotective activity of the 
extracts were in the order of AQCA (400 mg/ Kg, p.o.) 
> Silymarin (50 mg/Kg, p.o.) > ALCA (400 mg/Kg, p.o.) 
> AQCA (200 mg/Kg, p.o.) > ALCA (200 mg/Kg, p.o.). 
Phytoconstituents like phenolic compounds and 
tannins were reported for their hepatoprotective and 
antioxidant effect [29, 30] and these two were present 
in alcoholic and aqueous extracts. These active 




The result of present study clearly demonstrate that 
the various biochemical, (serum AST, ALT, ALP, 
albumin, total protein, direct bilirubin and total protein 
levels), physical (liver weight & volume) and 
histopathological alterations produced by paracetamol 
in the serum and tissue were reserved significantly by 
the pretreatment of extracts of Chenopodium album  
and Silymarin. This study confirms its use as 
hepatoprotective as per the ethno pharmacological 
claims. 
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